Eupraxia Pharmaceuticals ...
3.08
0.03 (0.98%)
At close: Jan 15, 2025, 3:58 PM
3.16
2.60%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -3.47 -3.03 -1.52 -22.21 -12.37 -6.71 -20.56
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 58.51 5.48 1.71 -4.19 -5.02 -8.03 14.85
P/FCF Ratio -4.63 -3.69 -2.31 -219.77 -17.14 -10.49 -15.82
P/OCF Ratio -4.64 -3.75 -2.38 -219.77 -17.17 -10.67 -16.76
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 4.72 0.82 0.47 -0.6 -0.67 -0.34 0.00
Quick Ratio 0.78 6.08 13.49 0.05 0.13 0.17 7.42
Current Ratio 0.78 6.08 13.49 0.05 0.13 0.17 7.42
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -23.36 -14.25 -16.1 -1.19 -4.2 -100.68 -94.13
Return on Equity (ROE) -16.87 -1.81 -1.13 0.19 0.41 1.20 -0.72
Return on Assets (ROA) -1.4 -0.9 -0.74 -2.75 -2.18 -4.55 -0.74
Return on Capital (ROIC) -31.36 -1.04 -0.72 0.11 0.35 1.25 -0.97
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a